top of page
PURE-Infusions-logo
vine.jpeg
brain_edited.png

Neurology
Infusions

Request Referral
CONDITIONS WE SERVE
neuro_edited.jpg
neuro_edited.jpg
symbols_edited_edited_edited_edited.png
neuro_edited.jpg
neuro_edited.jpg
symbols_edited_edited_edited_edited.png
Multiple Sclerosis (MS)
Myasthenia Gravis
CIDP
Multifocal Motor Neuropathy
Neuromyelitis Optica (NMO)
Other
Neurologic Conditions
NEUROLOGY THERAPIES
FDA-approved therapies used to treat neurologic conditions.
Iron Deficiency Anemia
sym_edited.png
INFUSION
sym_edited_edited.png
COMMON USES
sym_edited_edited.png
VISIT TIME
sym_edited_edited.png
SCHEDULE
Ocrevus®
(Ocrelizumab)
Multiple Sclerosis
2-4 Hours
Every 6 Months
Tysabri®
(Natalizumab)
Multiple Sclerosis
~1 Hour
Every 4 Weeks
Briumvi®
(Ublituximab)
Multiple Sclerosis
1-4 Hours
Every 6 Months
Vyvgart Hytrulo®
(Efgartigimod)
Myasthenia Gravis
30-90 Minutes
Cycled Therapy
2-6 hours
CIDP, MMN, Myasthenia Gravis
IVIG (Privigen®,Gamunex-C®,Gammagard®,Panzyga®)
 
Variable
Soliris®
(Eculizumab)
Myasthenia Gravis
Every 2 Weeks
35-60 Minutes
Ultomiris®
(Ravulizumab)
Myasthenia Gravis
1-3 hours
Every 8 Weeks
sym_edited.png
INFUSION
sym_edited_edited.png
COMMON USES
sym_edited_edited.png
VISIT TIME
sym_edited_edited.png
SCHEDULE
vine.jpeg
exclam_edited.png
Therapy selection, dosing, schedules, and visit times are determined solely by your prescribing physician based on your individual diagnosis, medical history, response to treatment, and current prescribing information. Infusion times and schedules listed are general approximations based on manufacture guidelines and may vary by patient, protocol, or clinical procedures. AURA Infusions does not prescribe or select therapies.  
bottom of page